Literature DB >> 14603579

Guidelines for management of osteoarthritis published by the American College of Rheumatology and the European League Against Rheumatism: why are they so different?

Edward Roddy1, Michael Doherty.   

Abstract

Because of different methodology the ACR and EULAR guidelines differ significantly in their recommendations despite an identical evidence base. Guidelines that use a strictly evidence-based approach are less likely to incur bias than those that rely more on expert consensus. Although expert consensus is useful in areas in which there are little trial data, clear delineation should be made between evidence-based statements and expert opinion. Following the dissemination of guidelines for the management of OA, emphasis should now be placed on discussion and implementation of the recommendations and subsequent revision of guidelines as new evidence comes to light.

Entities:  

Mesh:

Year:  2003        PMID: 14603579     DOI: 10.1016/s0889-857x(03)00063-2

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  13 in total

Review 1.  EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology.

Authors:  W Zhang; M Doherty
Journal:  Br J Sports Med       Date:  2006-08       Impact factor: 13.800

2.  Orthopedic surgeons feel that there is a treatment gap in management of early OA: international survey.

Authors:  Chuan Silvia Li; Jon Karlsson; Mitchell Winemaker; Parag Sancheti; Mohit Bhandari
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-06-18       Impact factor: 4.342

3.  Osteoarthritis: New Perspectives.

Authors:  Odile Gabay
Journal:  J Spine       Date:  2011-11-07

Review 4.  The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis.

Authors:  Antonio Gigante; Leonardo Callegari
Journal:  Rheumatol Int       Date:  2010-11-28       Impact factor: 2.631

5.  A 10-day course of SPA therapy is beneficial for people with severe knee osteoarthritis. A 24-week randomised, controlled pilot study.

Authors:  Mine Karagülle; Müfit Zeki Karagülle; Oğuz Karagülle; Arif Dönmez; Mustafa Turan
Journal:  Clin Rheumatol       Date:  2007-04-13       Impact factor: 2.980

6.  Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications.

Authors:  Angel Lanas; Juan-V Esplugues; Javier Zapardiel; Eduardo Sobreviela
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

7.  Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.

Authors:  Matthias Rother; Bernard J Lavins; Werner Kneer; Klaus Lehnhardt; Egbert J Seidel; Stefan Mazgareanu
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

8.  European Project on OSteoArthritis (EPOSA): methodological challenges in harmonization of existing data from five European population-based cohorts on aging.

Authors:  Laura A Schaap; Geeske Mee Peeters; Elaine M Dennison; Sabina Zambon; Thorsten Nikolaus; Mercedes Sanchez-Martinez; Estella Musacchio; Natasja M van Schoor; Dorly Jh Deeg
Journal:  BMC Musculoskelet Disord       Date:  2011-11-28       Impact factor: 2.362

9.  Is There a Clinically Meaningful Change in the Blood Pressure of Osteoarthritis Patients with Comorbid Hypertension During the Course of Balneotherapy?

Authors:  Emrullah Hayta; Mehmet Birhan Yılmaz; İlker Yayıkçı; Zafer Özer; Özlem Şahin
Journal:  N Am J Med Sci       Date:  2015-11

10.  Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee--study protocol for a randomized controlled trial.

Authors:  Claudia M Witt; Andreas Michalsen; Stephanie Roll; Antonio Morandi; Shivnarain Gupta; Mark Rosenberg; Ludwig Kronpass; Elmar Stapelfeldt; Syed Hissar; Matthias Müller; Christian Kessler
Journal:  Trials       Date:  2013-05-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.